A new drug application seeking the approval of ziftomenib was submitted to the FDA on April 8, 2025. This indication is for ...

Scientists at Scripps Research discover that apremilast, an FDA-approved anti-inflammatory drug, reduces both alcohol ...

The delay for Stealth Biotherapeutics comes amid a heightened focus on the impact FDA job cuts might have on drug reviews.